DURECT’s business strategy includes the establishing of partnerships with other biotechnology and pharmaceutical companies. This type of collaboration usually takes one of two forms:
If you represent a biotechnology or pharmaceutical company interested in discussing partnering opportunities with DURECT, please contact:
Michael Arenberg, J.D., M.B.A.
Senior Vice President, Corporate and Business Development